• About
  • Innovators
  • Corporates
  • Case Studies
  • Content Hub
Leading Edge Only Leading Edge Only
  • Login
  • Join
About
Innovators
Corporates
Case Studies
Content Hub

Nathaniel Milton

Leeds Beckett University, Principal Lecturer

This user is yet to add a description about themselves

User Verified
Register for free to view their full profile
Get Started

Connection Limit

You’ve reached your connections limit

Resets on {{ date }}

Contact us
  • Innovations
Published
Healthcare & Pharmaceuticals

Alzheimer's Diagnostic Marker

A novel peptide hormone has been identified as a potential marker for Alzheimer's disease, Type 2 Diabetes mellitus and Creutzfeldt-Jakob disease. A UK patent has been granted.

By Nathaniel Milton

Reference Number   05003

Last Update   Dec 19, 2018

Leading Edge Only
© 2025 Leading Edge Only LTD
  • About
  • About
  • Corporates
  • Innovators
  • Members
  • Partners
  • Help
  • Contact Us
  • Help Center / FAQs
  • Terms and Conditions
  • Privacy Policy
  • Cookie Policy
  • Acceptable Use Policy
  • Supported Browsers
  • Functions
  • Add your Innovation
  • Create your Challenge
  • Search Innovations
  • Explore
  • Challenges
  • Collaborators
  • Innovations
  • Members
  • Universities
  • Content Hub
  • Case Studies
  • Resources
  • Terms and Conditions
  • Privacy Policy
  • Cookie Policy
© 2025 Leading Edge Only LTD

Your experience on this site will be improved by allowing cookies.